Discover effective solutions for dry skin, eczema, acne scars, and psoriasis in this step-by-step skincare routine with ...
Still treating body care like an afterthought? See how a lightweight body lotion elevates daily skincare and keeps skin ...
Incorporating patient-reported outcome measures, such as quality of life, as well as looking into real-world data, is ...
Arcutis Biotherapeutics and Kowa Pharmaceuticals are cutting ties on their U.S. marketing partnership around Arcutis’ Zoryve ...
LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 23 scientific posters at Maui Derm Hawaii 2026 (Jan. 25-29), showcasing a comprehensive body of evidence across ...
It’s one thing when you find a holy grail skincare product for yourself, but when you find one that was used on the set of the hottest show? It’s a need.
Continued strong growth of ZORYVE® (roflumilast) in 2026 with full-year net product sales guidance of $455-$470 millionAdvancement of ZORYVE indication-expansion strategy beginning with ongoing Phase ...
FDA approved roflumilast topical foam 0.3% for plaque psoriasis, highlighting the role of PDE-4 inhibition and offering a steroid-free option for hair-bearing areas. Oral roflumilast showed potential ...
Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the treatment of plaque psoriasis. We conducted a phase 3, double-blind, randomized, ...
MAHARASHTRA, INDIA — When Babytai Suryavanshi first noticed a few scaly patches on her right forearm, she ignored them for three months, thinking it was an infection that would heal on its own. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results